Interleukin, Italian university to study IL-1 variations and incidence of early stroke

By Lisa Kerner

Charlotte, N.C., June 19 - Interleukin Genetics, Inc. said it is collaborating with Catholic University Center for High Technology Research and Education in Biomedical Sciences in Campobasso, Italy, to study the link between inflammation genetics and stroke in younger Italian men and women.

Researchers will analyze genetic material from about 460 subjects, half of whom have suffered a stroke at an early age, trying to identify unique IL-1 genetic patterns associated with both ischemic and hemorrhagic strokes.

An earlier study found significant correlation between IL-1 gene expression and early heart attack and stroke.

"This study will further strengthen the scientific backbone of Interleukin's core technology and genetic testing competencies and may support the development of new genetic tests that could provide important information about common diseases," Interleukin chief executive officer Ken Kornman said in a company news release.

Cardiovascular disease is now the leading cause of death in Italy, responsible for about 38% of all deaths, according to the World Health Organization.

Interleukin is a biotechnology company located in Waltham, Mass.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.